100,030 Shares in Core Scientific, Inc. (NASDAQ:CORZ) Purchased by Calamos Advisors LLC

Calamos Advisors LLC acquired a new stake in shares of Core Scientific, Inc. (NASDAQ:CORZ) in the fourth quarter, according to the company in its most recent filing with the SEC. The firm acquired 100,030 shares of the company’s stock, valued at approximately $1,405,000.

Several other large investors also recently added to or reduced their stakes in the stock. Wealth Enhancement Advisory Services LLC raised its stake in shares of Core Scientific by 25.6% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 98,077 shares of the company’s stock valued at $1,378,000 after acquiring an additional 20,000 shares in the last quarter. Highland Peak Capital LLC raised its position in Core Scientific by 37.9% during the 3rd quarter. Highland Peak Capital LLC now owns 413,584 shares of the company’s stock valued at $4,905,000 after purchasing an additional 113,584 shares in the last quarter. Mirabella Financial Services LLP purchased a new stake in shares of Core Scientific in the 3rd quarter worth $18,383,000. Van ECK Associates Corp grew its position in shares of Core Scientific by 22.9% during the 3rd quarter. Van ECK Associates Corp now owns 1,616,944 shares of the company’s stock worth $19,177,000 after buying an additional 300,942 shares in the last quarter. Finally, Capstone Investment Advisors LLC grew its position in shares of Core Scientific by 113.4% during the 3rd quarter. Capstone Investment Advisors LLC now owns 55,000 shares of the company’s stock worth $652,000 after buying an additional 29,230 shares in the last quarter.

Core Scientific Stock Down 1.0 %

Shares of NASDAQ:CORZ opened at $12.21 on Wednesday. Core Scientific, Inc. has a 52-week low of $2.61 and a 52-week high of $18.63. The stock has a market cap of $3.41 billion and a price-to-earnings ratio of -2.26. The business has a 50-day moving average price of $14.81 and a 200-day moving average price of $13.07.

Core Scientific (NASDAQ:CORZ) last posted its quarterly earnings results on Wednesday, November 6th. The company reported ($0.13) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.02). The business had revenue of $95.35 million for the quarter, compared to the consensus estimate of $94.80 million. As a group, equities analysts anticipate that Core Scientific, Inc. will post 0.5 EPS for the current fiscal year.

Insider Transactions at Core Scientific

In other Core Scientific news, insider Todd M. Duchene sold 129,861 shares of the company’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $14.24, for a total value of $1,849,220.64. Following the sale, the insider now owns 2,051,649 shares in the company, valued at approximately $29,215,481.76. This represents a 5.95 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, CEO Adam Taylor Sullivan sold 369,712 shares of the company’s stock in a transaction that occurred on Friday, January 24th. The stock was sold at an average price of $16.24, for a total value of $6,004,122.88. Following the completion of the sale, the chief executive officer now owns 3,758,793 shares in the company, valued at approximately $61,042,798.32. This represents a 8.96 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 744,032 shares of company stock worth $11,863,966 over the last 90 days.

Analyst Ratings Changes

CORZ has been the subject of a number of research reports. Needham & Company LLC reaffirmed a “buy” rating and issued a $18.00 price objective on shares of Core Scientific in a research note on Friday, January 17th. Jefferies Financial Group initiated coverage on Core Scientific in a research report on Monday, October 28th. They set a “buy” rating and a $19.00 target price on the stock. Keefe, Bruyette & Woods assumed coverage on Core Scientific in a research report on Monday, January 27th. They issued an “outperform” rating and a $22.00 price target for the company. B. Riley raised their price objective on Core Scientific from $16.00 to $17.00 and gave the company a “buy” rating in a research report on Thursday, November 7th. Finally, Macquarie increased their price target on shares of Core Scientific from $16.00 to $19.00 and gave the company an “outperform” rating in a research report on Thursday, November 14th. Fifteen equities research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, Core Scientific currently has an average rating of “Buy” and an average price target of $19.07.

Core Scientific Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.